Amersham is a world leader in medical diagnostics and in life sciences. Headquartered in the UK, we employ over 10,000 people around the world. Amersham shares (AHM) are traded on the London, New York and Oslo stock exchanges, and we are part of the FTSE Index of Britain’s 100 largest public companies.

Our medical diagnostics business, Amersham Health, provides diagnostic imaging agents which highlight organs, tissues and cells inside the human body, for the early detection, diagnosis and management of disease.

Our life sciences business, Amersham Biosciences, provides enabling technologies for gene and protein research, drug screening and testing, and protein separations systems for the manufacture of biopharmaceutical medicines.

We serve a broad range of customers in the healthcare market, from physicians, hospitals and purchasing groups to academic research laboratories, biotechnology firms and pharmaceutical companies. Our innovative products and technologies help our customers to diagnose and treat disease, to carry out research and to develop new treatments.